Remove Bioinformatics Remove Molecular Biology Remove Small Molecule
article thumbnail

Key industry partnerships advancing drug discovery

Drug Discovery World

Anagenex and Nimbus Therapeutics Anagenex and Nimbus Therapeutics have initiated a research collaboration to discover small molecule drugs for multiple challenging targets. The Chan Lab at UT Southwestern will enhance PhenoScope’s tumour bank with spatial transcriptomic data and provide bioinformatic analytic expertise.

article thumbnail

Therapeutic antibody potential in 2024

Drug Discovery World

The company also partnered with a top 20 pharma company and has been successful in identifying antibody candidates for a target of interest, with greater diversity (2.3x) and accuracy compared to alternative bioinformatics pipeline selection methods.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader.

article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . Engineering biosensors for specific functions . Biosensors have long been used as valuable tools for designing therapeutic strategies.

DNA 246